Furthermore, presence of stromal cells and a 3D ECM modulates the basal activity of the transcription factor STAT3 and consequently the migration and survival of GBM cells after anti-STAT3 inhibitor treatment. The gene discussed is STAT3; the disease is glioblastoma.